By Accenture LifeSciences |

The life sciences industry is in a state of transition as it shifts toward complex biopharmaceuticals and highly personalized medical therapies and devices. This shift is driving increased complexity in supply chain operations. Companies now manage smaller production batches, right down to the level of individual patients, while shortening fulfillment times from order to delivery. Read full article here.